On-Premises Molecular Imaging Market 2024 [Latest Trends]: Analysis Future Opportunity and Demand Forecast Year 2030

The Latest Research Report on On-Premises Molecular Imaging Market 2024 outlines the key factors influencing the growth of this area in terms of the competitive and geographic environment. In addition, the research discusses the obstacles to market growth and provides information on unexplored prospects that will promote company progress in the 2024-2030 forecast period.

Major Major Players are:

Hermes Medical Solutions, Bruker Corporation, GE Company, Fujifilm Holdings Corp., Koninklijke Philips N.V., Siemens AG, Toshiba Medical System Corp., Mirada Medical Limited, Carestream Health, Inc., Esaote SpA, Positron Corporation, Medisco Ltd., Hitachi Medical Corp., MIM Software Inc.

Get a sample PDF of the report in your inbox within 24 hours: https://www.cognatelifesciences.com/sample-request/2175/

On-Premises Molecular Imaging Market Overview:

On-Premises Molecular Imaging Market Industry Overview (2024 - 2030)

As of 2024, the global valuation of the On-Premises Molecular Imaging Market stood at $4.03 Billion, and there is a forecasted surge to $6.69 Billion by 2030. The market is poised to experience a compound annual growth rate (CAGR) of 7.5% over the analytical period spanning 2024 to 2030.

Molecular imaging, a facet of medical imaging focusing on visualizing molecules of medical significance within living patients, seamlessly integrates molecular and cellular biology with cutting-edge imaging technologies. This non-invasive and painless diagnostic method plays a crucial role in addressing various health conditions such as respiratory, gastrointestinal, cardiovascular, neurologic, and oncological disorders. Nuclear medicine, encompassing the field of molecular imaging, involves the use of minimal amounts of radioactive substances (radiopharmaceuticals) for diagnostic and therapeutic purposes. Molecular imaging not only facilitates enhanced personalization of patient care but also aids healthcare professionals in disease management.

The interdisciplinary domain of molecular imaging amalgamates molecular biology, chemistry, computer science, engineering, and medicine. Modern imaging techniques like optical imaging, computed tomography (CT), magnetic resonance imaging (MRI), positron emission tomography (PET), single-photon emission computed tomography (SPECT), and ultrasound are extensively employed to monitor structural, functional, and molecular alterations in cancer tissues globally.

The escalating prevalence of chronic diseases, including cancer, and the imperative need for early disease detection are driving the global molecular imaging market's expansion. According to the Centers for Disease Control and Prevention (CDC), liver cancer diagnoses in the United States alone amount to around 22,000 men and 9,000 women annually, with approximately 16,000 men and 8,000 women succumbing to the disease.

Covid-19 Impact on the Industry

The global molecular imaging equipment market experienced disruptions due to the COVID-19 pandemic, resulting in shortages of raw materials and labor, logistical challenges, and inefficiencies in regional warehouse operations. Despite these challenges, the employment of molecular imaging methods, such as positron emission tomography/computed tomography (PET/CT), gained prominence in detecting and managing COVID-19 cases, positively influencing the worldwide molecular imaging industry.

A July 2021 review in Seminars in Nuclear Medicine reported the significant agreement between MRI and chest CT in identifying COVID-19 pneumonia's characteristic features.

Market Drivers

Growing demand for molecular imaging techniques is anticipated to propel the global molecular imaging market growth over the forecast period

The global molecular imaging market is expected to witness growth propelled by the increasing demand for molecular imaging techniques, particularly in cancer diagnosis and prognosis. Techniques like positron emission tomography (PET), computed tomography (CT), magnetic resonance imaging (MRI), and others are in high demand globally.

Government Initiative will drive the market growth

Government initiatives emphasizing stronger regulatory controls and investments in healthcare and research and development (R&D) are anticipated to drive market growth. These investments aim to foster the development of more effective and non-invasive disease identification methods, especially in oncology and cardiology.

Increasing advances in technology will drive the market growth

Technological advancements, product introductions, and strategic partnerships by leading industry players are foreseen to boost the usage of molecular imaging. Automation through machine learning-based approaches for image categorization is expected to play a crucial role in the coming years.

Market Restraints

The high cost of imaging devices, such as MRI machines and CT scanners, poses a significant challenge to the growth of the global molecular imaging equipment market. High-end MRI devices, for instance, can cost over US$ 1 million, with prices starting at US$ 150,000.

Get a Impressive Discount on corporate email id @ https://www.cognatelifesciences.com/discount-request/2175/

Market Segmentation are:

Segmented by Modality (Positron Emission Tomography (PET), Positron Emission Tomography- Computed Tomography (PET-CT), Positron Emission Tomography- Magnetic Resonance (PET-MR), Single Photon Emission Computed Tomography (SPECT), Software, Magnetic Resonance, Molecular Ultrasound Imaging); Application (Cardiology, Oncology, Gastrointestinal Disorders, Neurology Disorders, Others); End-User (Hospitals, Ambulatory Surgical Centres, Diagnostic Centres)

On-Premises Molecular Imaging insights, overview and deep study of factors are considered to have greater influence over future course of the industry such as market size, market share, different dynamics of the industry, On-Premises Molecular Imaging market companies, regional analysis of the domestic markets, value chain analysis, consumption, demand, key application areas and more.

NOTE: Our report highlights the major issues and hazards that companies might come across due to the unprecedented outbreak of COVID-19.

How will this report benefit potential stakeholders?

-Comprehensive assessment of all opportunities and risks in the On-Premises Molecular Imaging market.
-The detailed study of business strategies for the growth of the On-Premises Molecular Imaging market-leading players.
-Conclusive study about the growth plot of the On-Premises Molecular Imaging market for forthcoming years.
-In-depth understanding of On-Premises Molecular Imaging market-particular drivers, constraints, and major micro markets.
-Favorable impression inside vital technological and market latest trends striking the On-Premises Molecular Imaging market.

Any Questions? Feel Free To Enquire Here. Well put you on the Right Path @ https://www.cognatelifesciences.com/enquiry-request/2175/

What On-Premises Molecular Imaging Market report offers:

On-Premises Molecular Imaging Market share assessments for the regional and country-level segments
Market share analysis of the top industry players
On-Premises Molecular Imaging Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
Strategic recommendations in key business segments based on the market estimations
Competitive landscape covering following points: Company Overview, Product Portfolio, Financial Performance, Recent Highlights, Strategies

COVID-19 has had a major impact on the world economy in addition to that on the public health. This particular pandemic had caused severe economic destruction and not a single country has been left unaffected. The virus has forced businesses around the globe to change the way they operate. This report gives an analysis of the COVID-19 aftermath on On-Premises Molecular Imaging market.

Competitive Rivalry:

The report highlights vital details based on the leading players in the global Industrial On-Premises Molecular Imaging market. It features their details such as product/business portfolio, market share, financial status, regional share, segment revenue, SWOT analysis, manufacturing base, capacities, production volume, major vendors, raw material sourcing strategies, organizational structure. Their latest corporate deals, joint ventures, mergers and acquisitions, product launches, and other brand promotions are other facts about the market players included in the report.

We also offer customization on reports based on specific client requirement:

1- country-level analysis for any 5 countries of your choice.

2- Competitive analysis of any market players.

3- 40 analyst hours to cover any other data points

Purchase this report now @ https://www.cognatelifesciences.com/buy-now/?id=2175&license_type=su

Finally, On-Premises Molecular Imaging Market is a valuable source of guidance for individuals and companies in decision framework.

Contact Us:
Robin McKay
Client Partner Relations
USA/Canada(Toll Free): 1800-601-6071
Mail: sales@cognatelifesciences.com
Web: www.cognatelifesciences.com

About us :

Cognate Lifesciences is a specialized hub for all market research reports related to Lifesciences Market. Some of the sub domains covered by our team are Pharmaceuticals, Medical Devices and Supplies, Healthcare, Diagnostics, Biotech, Therapeutics, Healthcare IT etc. We offer syndicated/customized market research studies along with advisory and consulting services.

This release was published on openPR.